Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 12/07/2024 17:05
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.
Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they...
THURSDAY, March 19, 2026 -- Diabetes mellitus (DM) is associated with an elevated risk for dementia, with the highest risk for type 1 diabetes...
THURSDAY, March 19, 2026 -- Diabetes mellitus (DM) is associated with an elevated risk for dementia, with the highest risk for type 1 diabetes...
Metformin is usually the first-choice for the treatment of type 2 diabetes. This drug mainly works by lowering glucose production in the liver. It...
Months of stopping can undo years of progress...
Months of stopping can undo years of progress...
Researchers identify strategy to slow memory loss in Alzheimer’s New York researchers have discovered a way to slow memory loss and boost learning...
The researchers estimated that people with type 1 diabetes were nearly three times as likely to develop dementia as people without diabetes.
DelveInsight’s, “Checkpoint Inhibitors Competitive landscape 2026” report provides comprehensive insights about 50+ companies and...
While diabetes medications are not considered as targeting the brain, the study, published in the journal Science Advances, shows that metformin has...